MARKET

SNES

SNES

Senestech Inc
NASDAQ
0.3505
-0.0412
-10.52%
After Hours: 0.3663 +0.0158 +4.51% 16:19 09/30 EDT
OPEN
0.3847
PREV CLOSE
0.3917
HIGH
0.4013
LOW
0.3500
VOLUME
31.17K
TURNOVER
0
52 WEEK HIGH
1.685
52 WEEK LOW
0.3372
MARKET CAP
4.28M
P/E (TTM)
-0.4435
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers
Benzinga · 2d ago
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Gainers
Benzinga · 2d ago
SenesTech's Return On Capital Employed Overview
Benzinga Pro data, SenesTech (NASDAQ:SNES) reported Q2 sales of $277 thousand. Earnings fell to a loss of $2.57 million, resulting in a 10.16% decrease from last quarter.
Benzinga · 09/08 14:36
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers SenesTech (NASDAQ:SNES) stock rose 28.0% to $0.64 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million.
Benzinga · 09/01 21:40
SenesTech Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that its Board of Directors...
PR Newswire · 08/26 20:05
Senestech, Inc. (SNES) Reports Q2 Loss, Lags Revenue Estimates
Senestech, Inc. (SNES) delivered earnings and revenue surprises of -10.53% and 24.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/11 21:35
BRIEF-Senestech Reports Qtrly Net Loss Per Share $0.21
BRIEF-Senestech Reports Qtrly Net Loss Per Share $0.21
Reuters · 08/11 21:33
SenesTech GAAP EPS of -$0.21 misses by $0.02, revenue of $2.77M beats by $2.4M
SenesTech press release (NASDAQ:<a href="h...
Seekingalpha · 08/11 20:24
More
About SNES
SenesTech, Inc. is developing and commercializing a global technology for managing animal pest populations, initially rat populations, through fertility control. The Company’s product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest limits the reproduction of male and female rats beginning with the first breeding cycle following consumption. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. VCD is an occupational chemical that selectively destroys ovarian follicles in rats. The Company also continues to research and develop enhancements to ContraPest that align with its target verticals and other potential fertility control options for additional species. The Company is developing a fertility control product for mice. The Company has also developed preliminary data with feral dogs, feral pigs, wallabies and brushtail possums.

Webull offers kinds of SenesTech Inc stock information, including NASDAQ:SNES real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNES stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNES stock methods without spending real money on the virtual paper trading platform.